ArticleSleep & breathing = Schlaf & Atmung2023
Potential health risks of sound abatement material in positive airway pressure devices for sleep breathing disorders: a summary of studies to date.
Article in Sleep & breathing = Schlaf & Atmung, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Philips leaving the United States: what does that mean for physicians, patients, and everyone in between?Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024Article
- Veterans Health Administration response to 2021 recall of Philips Respironics devices: A case study.Frontiers in sleep · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe potential carcinogenic and airway irritation risks of polyester-based polyurethane (PE-PUR) contained in sound-absorbing foam in positive airway pressure (PAP) devices have raised many concerns. We summarize the currently available studies to assess the potential health risks of PE-PUR.
methodsWe searched Pubmed and Web of Science for studies on the safety of PAP devices containing PE-PUF and performed a systematic analysis of the cancer risk.
resultsPE-PUR did not increase the cancer risk (OR: 1.08, 95% CI: 0.99-1.17, I2 = 0%). Patients in the group of PE-PUR devices had increased airway irritation, and they had higher rates of using short-acting beta-agonists and oral corticosteroids (SABA: 9.4% vs. 8.8%, p = 0.047; OCS: 19.7% vs. 17.3%, p < 0.001).
conclusionThe application of PE-PUF can increase airway irritation, but there is no evidence for its potential carcinogenicity.
Indexed as
Identifiers
36520338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.